FindTrial
Sign In

Safety Evaluations of "OKYURINGU" which is a new drug delivery system device in ophthalmic field.

Safety Evaluations of "OKYURINGU" which is a new drug delivery system device in ophthalmic field. - Safety Evaluations of "OKYURINGU" for Ocular Surface.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000024445
Enrollment
12
Registered
2016-10-17
Start date
2016-10-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy humans

Interventions

Continuous wearing 8 hours or 24 hours, to consider the safety of the ocular surface

Sponsors

hokkaido University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Those who do not have the eye disease.

Exclusion criteria

Exclusion criteria: The one with an ocular disease.

Design outcomes

Primary

MeasureTime frame
Adverse events after the "OKYURINGU" wearing.—

Countries

Japan

Contacts

Public ContactTakeshi Ohguchi

Hokkaido University Ophthalmology

tohguchi@med.hokudai.ac.jp011-706-5944

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026